Trends
Samsung Medison to acquire French AI ultrasound startup Sonio for $92.7M
Samsung Medison, a medical device specialises in developing diagnostic imaging devices, said on Wednesday it plans to acquire Sonio.
Headline
Samsung Medison, a medical device specialises in developing diagnostic imaging devices, said on Wednesday it plans to acquire Sonio.
Context
Samsung Medison, a medical device unit of Samsung Electronics, plans to acquire Sonio , a Paris-based startup specialising in AI-powered software for ultrasound workflows, for about $92.7 million. Also read: AI advances bring Samsung’s memory chip business back to life
Evidence
Pending intelligence enrichment.
Analysis
Samsung Medison said Sonio’s software would help it bring better AI-driven imaging workflows to the market. Samsung Electronics, which owns a 68.45% stake in the medical device unit, acquired Medison for $22 million in 2011. Samsung said in a statement that following the acquisition, Sonio will remain an independent company and continue to grow commercially and offer products and services in France. Also read: Samsung says AI will drive technology demand in second half Co-founded by Cecile Brosset and Remi Besson in 2020, Sonio most recently secured $14 million in a Series A led by Cross Border Impact Ventures in August 2023 . The company has raised a total of $27.2 million, according to Tracxn , and its investors include Elaia, Bpifrance French Tech Seed, OneRagtime, and a few angel investors.
Key Points
- Samsung Medison, a medical device unit of Samsung Electronics that specialises in developing diagnostic imaging devices, said on Wednesday it plans to acquire Sonio.
- The French startup’s AI assistant assists obstetricians and gynecologists with ultrasound exams and has FDA 510(k) clearance for Sonio Detect.
- Samsung Medison said Sonio’s software would help it bring better AI-driven imaging workflows to the market.
Actions
Pending intelligence enrichment.
